Abbott Laboratories (WBO:ABT) 3-Year Revenue Growth Rate : 5.80% (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Abbott Laboratories 3-Year Revenue Growth Rate?

Abbott Laboratories's Revenue per Share for the three months ended in Dec. 2023 was €5.38.

During the past 12 months, Abbott Laboratories's average Revenue per Share Growth Rate was -7.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 5.80% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Abbott Laboratories was 15.20% per year. The lowest was -17.90% per year. And the median was 9.70% per year.

Competitive Comparison of Abbott Laboratories's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Abbott Laboratories's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Abbott Laboratories's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's 3-Year Revenue Growth Rate falls into.

Abbott Laboratories 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

Abbott Laboratories (WBO:ABT) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.

Abbott Laboratories 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories (WBO:ABT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (WBO:ABT) » Definitions » 3-Year Revenue Growth Rate

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Chile ABT:Switzerland ABTT34:Brazil ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.